S4L (p.Ser4Leu) variant of NPM1 (Nucleophosmin)

S4L (p.Ser4Leu) in NPM1 (Nucleophosmin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.32 / 1. The record also includes structural context.

S4L (p.Ser4Leu) variant details